CPIX
NASDAQ · Pharmaceuticals
Cumberland Pharmaceuticals
$4.68
+0.39 (+9.09%)
Open$4.30
Previous Close$4.29
Day High$4.81
Day Low$4.30
52W High$6.27
52W Low$1.85
Volume—
Avg Volume437.4K
Market Cap69.10M
P/E Ratio—
EPS$-0.19
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+657.5% upside
Current
$4.68
$4.68
Target
$35.45
$35.45
$27.92
$35.45 avg
$53.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 49.78M | 48.83M | 7.91M |
| Net Income | -3,170,941 | -2,799,261 | 1.22M |
| Profit Margin | -6.4% | -6.1% | 15.4% |
| EBITDA | 1.51M | 1.41M | 2.16M |
| Free Cash Flow | — | — | 556.1K |
| Rev Growth | +2.0% | +2.0% | +3.2% |
| Debt/Equity | 0.21 | 0.21 | 0.66 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |